Structure-activity relationships of adenosines with heterocyclic N6-substituents

被引:34
作者
Ashton, T. D. [1 ]
Aumann, Kylee M. [2 ,3 ]
Baker, Stephen P. [4 ]
Schiesser, Carl H. [2 ,3 ]
Scammells, Peter J. [1 ]
机构
[1] Monash Univ, Victorian Coll Pharm, Dept Med Chem, Parkville, Vic 3052, Australia
[2] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia
[3] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Melbourne, Vic 3010, Australia
[4] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
基金
澳大利亚研究理事会;
关键词
adenosine; A(1)AR agonist;
D O I
10.1016/j.bmcl.2007.10.028
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Two series of N-6-substituted adenosines with monocyclic and bicyclic N-6 substituents containing a heteroatom were synthesized in good yields. These derivatives were assessed for their affinity ([H-3]CPX), potency, and intrinsic activity (cAMP accumulation) at the A, adenosine receptor in DDT1 MF-2 cells. In the monocyclic series, the N-6-tetrahydrofuran-3-yl and thiolan-3-yl adenosines (1 and 26, respectively) were found to possess similar activities, whereas the corresponding selenium analogue 27 was found to be more potent. A series of nitrogen containing analogues showed varying properties, N-6-((3R)-1-benzyloxycarbonylpyrrolidin-3-yl)adenosine (30) was the most potent at the AIAR; IC50 = 3.2 nM. In the bicyclic series, the effect of a 7-azabicyclo[2.2.1]heptan-2-yl substituent in the N-6-position was explored. N6- (7-Azabicyclo[2.2.1] heptan-2-yl)adeno sine (38) proved to be a reasonably potent A, agonist (K-i = 51 nM, IC50 = 35 nM) while further substitution on the 7 ''-nitrogen with tert-butoxycarbonyl (31, IC50 = 2.5 nM) and 2-bromobenzyloxycarbonyl (34, IC50 = 9.0 nM) gave highly potent A(1)AR agonists. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6779 / 6784
页数:6
相关论文
共 24 条
  • [1] Structure-activity relationships of 2,N6,5′-substituted adenosine derivatives with potent activity at the A2B adenosine receptor
    Adachi, Hayamitsu
    Palaniappan, Krishnan K.
    Ivanov, Andrei A.
    Bergman, Nathaniel
    Gao, Zhan-Guo
    Jacobson, Kenneth A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) : 1810 - 1827
  • [2] Synthesis and biological evaluation of novel N6-[4-(substituted) sulfonamidophenylcarbamoyl]adenosine-5′-uronamides as A3 adenosine receptor agonists
    Baraldi, PG
    Fruttarolo, F
    Tabrizi, MA
    Romagnoli, R
    Preti, D
    Bovero, A
    de Las Infantas, MJP
    Moorman, A
    Varani, K
    Borea, PA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (22) : 5535 - 5540
  • [3] Synthesis and biological evaluation of novel 1-deoxy-1-[6-[((hetero)arylcarbonyl)hydrazino]-9H-purin-9-yl]-N-ethyl-β-D-ribofuranuronamide derivatives as useful templates for the development of A2B adenosine receptor agonists
    Baraldi, Pier Giovanni
    Preti, Delia
    Tabrizi, Mojgan Aghazadeh
    Fruttarolo, Francesca
    Romagnoli, Romeo
    Carrion, Maria Dora
    Lopez Cara, Luisa Carlota
    Moorman, Allan R.
    Varani, Katia
    Borea, Pier Andrea
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (02) : 374 - 380
  • [4] Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A1-adenosine receptor
    Beauglehole, AR
    Baker, SP
    Scammells, PJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (26) : 4973 - 4980
  • [5] STRUCTURAL REQUIREMENTS OF NUCLEOSIDES FOR BINDING BY ADENOSINE DEAMINASE
    CORY, JG
    SUHADOLNIK, RJ
    [J]. BIOCHEMISTRY, 1965, 4 (09) : 1729 - +
  • [6] DEHMLOW EV, 1992, SYNTHESIS-STUTTGART, P947
  • [7] Pharmacology and therapeutic applications of A1 adenosine receptor ligands
    Dhalla, AK
    Shryock, JC
    Shreeniwas, R
    Belardinelli, L
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2003, 3 (04) : 369 - 385
  • [8] New, optically active phosphine oxazoline (JM-Phos) ligands: Syntheses and applications in allylation reactions
    Hou, DR
    Reibenspies, JH
    Burgess, K
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 2001, 66 (01) : 206 - 215
  • [9] New potent and selective A1 adenosine receptor agonists
    Hutchinson, SA
    Baker, SP
    Linden, J
    Scammells, PJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (18) : 4877 - 4884
  • [10] A1 adenosine receptor agonists:: Medicinal chemistry and therapeutic potential
    Hutchinson, SA
    Scammells, PJ
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (17) : 2021 - 2039